Showing results (1791-1800 of 1,929) with videos related to

Sort By:
Pageof 193
Open Heart|November 7, 2022
Design and rationale of the inferior vena CAVA and Lung UltraSound-guided therapy in Acute Heart Failure (CAVAL US-AHF Study): a randomised controlled trialLucrecia Maria Burgos, Rocio Baro Vila, Ailin Goyeneche, et al.
Open Heart|August 31, 2021
Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015-2016Amalie Nilsen, Tove Aminda Hanssen, Knut Tore Lappegård, et al.
Open Heart|February 9, 2023
Mobile-phone text messaging to promote ideal cardiovascular health in womenMonica Acevedo, Paola Varleta, Carolina Casas-Cordero, et al.
Open Heart|February 7, 2023
Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registryTanja Rudolph, Michal Droppa, Jan Baan, et al.
Open Heart|February 16, 2023
Contemporary percutaneous management of coronary calcification: current status and future directionsBreda Hennessey, Nilesh Pareek, Fernando Macaya, et al.
Open Heart|March 3, 2025
Patterns of systolic blood pressure response at the end of exercise and mortality and morbidity in patients referred for exercise testingAnna Carlén, Thomas Lindow, Nicholas Cauwenberghs, et al.
Open Heart|March 3, 2025
Durable versus biodegradable polymer drug-eluting stents in all-comersThierry Witzig, Serban Puricel, Alain Witzig, et al.
Open Heart|February 28, 2025
Impact of iron deficiency on congestion and postdischarge survival in patients recently hospitalised for decompensated heart failure: a multicentre, prospective, observational analysis of the FERIC-RO studyCornelia Margineanu, Laura Antohi, Andrew Ambrosy, et al.
Open Heart|February 28, 2025
Recovery of cardiovascular testing in Asia during the COVID-19 pandemic: findings from the INCAPS COVID 2 studyKathy Z Dai, Luca Bremner, Yosef Cohen, et al.
Open Heart|February 23, 2025
Efficacy of cardiac myosin inhibitors mavacamten and aficamten in hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomised controlled trialsAyesha Aman, Arfa Akram, Bisma Akram, et al.
Pageof 193